🇺🇸 FDA
Patent

US 9677062

Hyaluronidase and factor VIII compositions

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 9677062 (Hyaluronidase and factor VIII compositions) held by HALOZYME, INC. expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HALOZYME, INC.
Grant date
Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2039/505, A61K38/00, A61K38/47, A61K39/395